Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v2.4.0.8
Consolidated Statements of Stockholders' Equity (USD $)
Common Stock
Additional Paid in Capital
Deficit Accumulated During the Development Stage
Accumulated Other Comprehensive Loss
Total
Balance at Nov. 27, 2012               
Balance (in shares) at Nov. 27, 2012           
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Founders' shares issued at $0.002 per share 95 855     950
Founders' shares issued at $0.002 per share (in shares) 950,000        
Net loss     (950)   (950)
Balance at Nov. 30, 2012 95 855 (950)     
Balance (in shares) at Nov. 30, 2012 950,000       950,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Founders' shares issued at $0.002 per share 238 4,512     4,750
Founders' shares issued at $0.002 per share (in shares) 2,375,000        
Common shares issued for cash at $0.02 per share 250 49,750     50,000
Common shares issued for cash at $0.02 per share (in shares) 2,500,000        
Foreign currency translation adjustments       (102) (102)
Net loss     (18,244)   (18,244)
Balance at Nov. 30, 2013 $ 583 $ 55,117 $ (19,194) $ (102) $ 36,404
Balance (in shares) at Nov. 30, 2013 5,825,000       5,825,000